Vivosim Labs, Inc. (VIVS) — 8-K Filings

All 8-K filings from Vivosim Labs, Inc.. Browse 21 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (21)

  • VivoSim Labs Files 8-K on Shareholder Votes & Financials — Dec 18, 2025 Risk: low
    VivoSim Labs, Inc. filed an 8-K on December 18, 2025, reporting on matters submitted to a vote of security holders and financial statements as of December 16, 2
  • VivoSim Labs Files 8-K on Officer/Director Changes — Aug 14, 2025 Risk: medium
    VivoSim Labs, Inc. filed an 8-K on August 14, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain o
  • VivoSim Labs Files 8-K — May 6, 2025 Risk: low
    VivoSim Labs, Inc. filed an 8-K on May 6, 2025, reporting other events and financial statements as of April 30, 2025. The company, formerly known as Organovo Ho
  • VivoSim Labs Files 8-K with Corporate Updates — Apr 24, 2025 Risk: low
    VivoSim Labs, Inc. filed an 8-K on April 24, 2025, reporting an amendment to its Articles of Incorporation or Bylaws, a Regulation FD disclosure, and other even
  • Organovo Holdings Files 8-K — Apr 23, 2025 Risk: low
    Organovo Holdings, Inc. filed an 8-K on April 23, 2025, to report current information. The filing indicates no specific material events or financial updates wer
  • Organovo Holdings Files 8-K on Financials — Apr 2, 2025 Risk: low
    Organovo Holdings, Inc. filed an 8-K on April 2, 2025, reporting on its results of operations and financial condition. The filing also includes information on R
  • Organovo Holdings Files 8-K — Mar 27, 2025 Risk: low
    Organovo Holdings, Inc. filed an 8-K on March 27, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The company, previously k
  • Organovo Holdings Announces Executive Departures and Board Changes — Mar 26, 2025 Risk: medium
    Organovo Holdings, Inc. announced on March 21, 2025, the departure of its Chief Financial Officer, David Harris, effective March 21, 2025. The company also repo
  • Organovo Holdings Files 8-K with Corporate Changes — Mar 21, 2025 Risk: medium
    Organovo Holdings, Inc. filed an 8-K on March 21, 2025, reporting material modifications to the rights of security holders and amendments to its articles of inc
  • Organovo Holdings Files 8-K — Mar 19, 2025 Risk: low
    Organovo Holdings, Inc. filed an 8-K on March 19, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain
  • Organovo Holdings Files 8-K — Mar 6, 2025 Risk: low
    Organovo Holdings, Inc. filed an 8-K on March 6, 2025, reporting other events and financial statements. The company, formerly known as Real Estate Restoration &
  • Organovo Holdings Faces Delisting Concerns — Feb 25, 2025 Risk: high
    Organovo Holdings, Inc. filed an 8-K on February 25, 2025, reporting a material definitive agreement and a notice of delisting or failure to satisfy a continued
  • Organovo Holdings Faces Delisting Concerns — Jan 17, 2025 Risk: high
    Organovo Holdings, Inc. filed an 8-K on January 17, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The compan
  • Organovo Holdings Files 8-K on Officer/Director Changes — Dec 31, 2024 Risk: medium
    Organovo Holdings, Inc. filed an 8-K on December 23, 2024, reporting on the departure of directors or certain officers, the election of directors, the appointme
  • Organovo Holdings Reports Director Changes and Compensatory Arrangements — Nov 22, 2024 Risk: low
    Organovo Holdings, Inc. filed an 8-K on November 20, 2024, reporting on the departure of directors, election of new directors, appointment of officers, and comp
  • Organovo Holdings Announces Board and Executive Changes — Aug 9, 2024 Risk: medium
    Organovo Holdings, Inc. announced on August 5, 2024, a change in its board of directors and executive compensation arrangements. Specifically, the company filed
  • Organovo Holdings Faces Delisting Notice — Jul 24, 2024 Risk: high
    Organovo Holdings, Inc. filed an 8-K on July 24, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule. The company, formerly kno
  • Organovo Holdings Files 8-K for Material Agreement — May 13, 2024 Risk: medium
    Organovo Holdings, Inc. filed an 8-K on May 13, 2024, reporting a material definitive agreement entered into on May 8, 2024. The filing also includes other even
  • Organovo Holdings Files 8-K — May 1, 2024 Risk: low
    Organovo Holdings, Inc. filed an 8-K on May 1, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain spe
  • Organovo Holdings Files 8-K — Apr 23, 2024 Risk: low
    Organovo Holdings, Inc. filed an 8-K on April 23, 2024, reporting an event on April 19, 2024. The filing is primarily for "Other Events" and "Financial Statemen
  • Organovo Holdings Files Routine 8-K, Confirms Nasdaq Listing — Feb 7, 2024
    Organovo Holdings, Inc. (ONVO) filed an 8-K on February 7, 2024, to disclose general corporate information and confirm its status as a publicly traded company o

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.